55 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
and payment obligations; compliance with anti-corruption, sanctions and trade control laws; environmental risks; and the impact of sustainability issues
8-K
EX-99.1
mglwsu7vca4 hzxr
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
paqo97770p7
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
5sw9xogshokjzl a0bx
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
EX-99.1
0stjzs 4h89
2 Aug 23
Results of Operations and Financial Condition
7:00am
SD
EX-1.01
iap edm6tmccpgtvulu
24 May 23
Conflict minerals disclosure
12:00am
8-K
EX-99.1
m2nc6e
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
xrlclsdr5j 1om
26 Jul 22
Key financial highlights and outlook
4:56pm
SD
EX-1.01
nupn4 cu46m913kricd
25 May 22
Conflict minerals disclosure
8:00am